All mpox articles
-
NewsOne dose of smallpox vaccine moderately effective in preventing mpox infection
One dose of modified vaccinia Ankara-Bavarian Nordic (MVA-BN) smallpox vaccine is moderately effective in preventing mpox infection and should be made available to communities at risk, finds a new study.
-
NewsInvestigational mpox mRNA vaccine reduces disease severity in primates compared to available vaccines
A new mpox vaccine candidate more effectively limits symptoms and disease duration in primates that were infected with a lethal strain of the mpox virus when compared to a currently licensed modified vaccinia Ankara (MVA) vaccine.
-
NewsWHO declares mpox outbreak a public health emergency of international concern
WHO Director-General Dr Tedros Adhanom Ghebreyesus has declared that the upsurge of mpox in the Democratic Republic of the Congo and a growing number of countries in Africa constitutes a public health emergency of international concern.
-
NewsWHO convenes Emergency Committee to tackle mpox surge in Congo and neighbours
WHO Director-General Tedros Adhanom Ghebreyesus announced the convening of an Emergency Committee under International Health Regulations to advise on whether the Africa outbreak represents a public health emergency of international concern.
-
NewsSyphilis cases are rising, but many people don’t know the symptoms
Syphilis cases are on the rise around the globe, but many Americans don’t know the symptoms. Just over half know that a case of syphilis can be permanently cured and most either mistakenly think there is a vaccine to prevent it or are unsure.
-
NewsMpox circulating at low numbers among gay and bisexual men who have sex with men
While mpox cases have sharply declined since the 2022 global outbreak, they continue to occur in the U.S. among gay and bisexual men who have sex with men (GBMSM), according to a new study.
-
NewsScientists uncover factors potentially contributing to the decline of the mpox outbreak
Researchers hypothesise that it is not likely that preventive vaccination was a driver of the outbreak’s decline in the Netherlands, as the mpox incidence started to decline before the start of the vaccination programme.
-
NewsLower dose of mpox vaccine is safe and generates six-week antibody response equivalent to standard regimen
A dose-sparing intradermal mpox vaccination regimen was safe and generated an antibody response equivalent to that induced by the standard regimen at six weeks (two weeks after the second dose), according to new findings.
-
NewsGay and bisexual men diagnosed with mpox faced substantial stigma
Gay and bisexual men who were diagnosed with mpox during the 2022 outbreak in England faced substantial issues related to stigma and potentially poor-quality care when accessing services, finds a new study.
-
NewsNew research defines specific genomic changes associated with the transmissibility of the monkeypox virus
Scientists have located and identified alterations in the monkeypox virus genome that potentially correlate with changes in the virus’s transmissibility observed in the 2022 outbreak.
-
NewsCase report shows mpox breakthrough infection in man who had received both vaccine doses
New research details the case of a man who had received two doses of the monkey pox vaccine in Autumn, 2022 yet experienced a ‘breakthrough’ mpox infection in January 2024.
-
NewsStudy shows Mpox (monkeypox) antibodies wane within a year of vaccination
New research shows that the antibodies produced by Modified Vaccinia virus Ankara - Bavarian Nordic (MVA-BN) vaccination against mpox wane significantly within a year of receiving the vaccination.
-
NewsSignificant decline of neutralising antibodies to monkeypox virus during the first month after vaccination
New research shows that even in men who receive two doses of mpox vaccine intradermally, their level of antibodies to the virus falls to low or zero within the first few months if they have not received a previous smallpox vaccine.
-
NewsScientists report positive immune response against mpox using a vaccine
Scientists at one of the largest cancer research and treatment organizations in the United States show that its COVID-19 vaccine also protects against mpox.
-
NewsResearchers deploy CRISPR to develop faster mpox testing
Using gene editing proteins combined with nanopore sensing technology, new research shows that testing for pathogens could become faster and more accessible.
-
NewsSmallpox vaccine induces immunity against monkeypox infection in people living with HIV
Researchers have shown that intradermal vaccination with the JYNNEOS vaccine against smallpox is the best option to protect people living with HIV from contracting the monkeypox virus.
-
NewsMpox vaccine triggers equally strong immune response in smaller doses
Delivering the two-dose mpox vaccine in smaller than the usual FDA-approved doses produced a detectable immune response. This also occurred regardless of whether people were living with or without HIV.
-
NewsMpox infections less severe in those vaccinated or previously infected
A new study has shown mpox (formerly known as monkeypox) infections to be less severe among those who are vaccinated or had a previous infection in 2022, underlining the importance and effectiveness of vaccination.
-
NewsNew VDEC is ‘step change’ for UK’s growing vaccine capabilities
The UK Health Security Agency has unveiled its world-leading Vaccine Development and Evaluation Centre at Porton Down, which will be at the forefront of the UK’s ability to develop vaccines against the world’s deadliest pathogens.
-
NewsFirst rapid test for mpox can be tailored for other emerging diseases
The first rapid test for mpox has been developed - the selective molecular sensor can detect the virus within minutes, without the use of any high-end instrumental techniques.
